Express
Windtree Signs $520 Million New Financing Agreement to Strengthen BNB Reserve Strategy
Summary: According to reports, NASDAQ-listed biotechnology company Windtree Therapeutics (WINT) has announced the signing of a potential $500 million common stock purchase agreement to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp. The total financing amount for this round ...
According to reports, NASDAQ-listed biotechnology company Windtree Therapeutics (WINT) has announced the signing of a potential $500 million common stock purchase agreement to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp. The total financing amount for this round reaches up to $520 million, with 99% of the funds earmarked for purchasing BNB. The company plans to officially initiate the use of funds after obtaining shareholder approval to increase the number of authorized common shares.
Tags:
Link: Windtree Signs $520 Million New Financing Agreement to Strengthen BNB Reserve Strategy [Copy]
